A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases

NCT07412691 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Diseases

Interventions

BIOLOGICAL: BG-A3004
BIOLOGICAL: Placebo

Sponsor

BeOne Medicines